Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Advanced Human Imaging Ltd. ( (AU:AHI) ) just unveiled an update.
Advanced Health Intelligence Ltd. has released an updated investor presentation available on their website, showcasing their innovation in smartphone technology to transform healthcare. The presentation highlights their B2B approach and industry-leading solutions using digital biomarkers to assess risks of various health conditions. It further outlines AHI’s expanding product portfolio, strategic partnerships, and their extensive patent portfolio underscoring their technological advantage. The company’s focus on digital-first healthcare solutions aims to enhance early detection and proactive health management globally, offering cost-effective access to health risk assessment for billions of smartphone users.
More about Advanced Human Imaging Ltd.
Advanced Health Intelligence Ltd. operates in the digital health technology industry, focusing on smartphone-based health risk identification solutions. The company leverages cutting-edge technology including machine learning, AI, and computational systems biology to provide digital health risk assessments. Their offerings enable individuals to conduct comprehensive health assessments using smartphone sensor technology, facilitating timely healthcare interventions across global markets including healthcare, insurance, large enterprises, and government sectors.
YTD Price Performance: 6.25%
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$20.52M
For an in-depth examination of AHI stock, go to TipRanks’ Stock Analysis page.
